These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
310 related articles for article (PubMed ID: 14962580)
21. Controlling the quality of Uncle Sam's drugs. Hecht A FDA Consum; 1977 May; 11(4):22-3. PubMed ID: 10316531 [No Abstract] [Full Text] [Related]
22. Improving drug quality through certification experience. Weiss PJ Am J Pharm Sci Support Public Health; 1974; 146(3):86-90. PubMed ID: 4852375 [No Abstract] [Full Text] [Related]
23. Assuring the quality of the nation's drugs. Interview by William E. Small. Michels D Am Pharm; 1980 Apr; NS20(4):40-2. PubMed ID: 7386377 [No Abstract] [Full Text] [Related]
24. [Control of drugs in foreign countries]. Buriánek J; Parrák V Cesk Farm; 1973 Jul; 22(6):247-53. PubMed ID: 4732551 [No Abstract] [Full Text] [Related]
25. Securing the US pharmaceutical supply. Somberg JC Am J Ther; 2008; 15(3):197. PubMed ID: 18496255 [No Abstract] [Full Text] [Related]
26. Crystal engineering of the composition of pharmaceutical phases. Do pharmaceutical co-crystals represent a new path to improved medicines? Almarsson O; Zaworotko MJ Chem Commun (Camb); 2004 Sep; (17):1889-96. PubMed ID: 15340589 [TBL] [Abstract][Full Text] [Related]
27. Pharma's year of trouble and strife. Frantz S Nat Rev Drug Discov; 2006 Jan; 5(1):7-9. PubMed ID: 16485339 [No Abstract] [Full Text] [Related]
28. Use of microbiology in drug monitoring. Kirshbaum A Bull Parenter Drug Assoc; 1971; 25(5):226-32. PubMed ID: 5109889 [No Abstract] [Full Text] [Related]
30. Institute of Medicine's new drug safety report: implications for Canada. Cassels A CMAJ; 2006 Dec; 175(12):1515-6. PubMed ID: 17146086 [No Abstract] [Full Text] [Related]
31. Combination products regulation at the FDA. Lauritsen KJ; Nguyen T Clin Pharmacol Ther; 2009 May; 85(5):468-70. PubMed ID: 19381151 [TBL] [Abstract][Full Text] [Related]
32. Development of specifications for biotechnology products--perspective from Europe. Trouvin JH Dev Biol Stand; 1997; 91():25-30. PubMed ID: 9413679 [No Abstract] [Full Text] [Related]
33. Standardization of forensic drug analyses. Frank RS; Gunn JW J Forensic Sci; 1974 Jan; 19(1):163-7. PubMed ID: 4854386 [No Abstract] [Full Text] [Related]
34. Pharmacogenomics. Going from genome to pill. Service RF Science; 2005 Jun; 308(5730):1858-60. PubMed ID: 15976283 [No Abstract] [Full Text] [Related]
36. Report on the PQRI impurity characterization and quantification best practices survey. Faustino P; Chan CC; Carrano J; Gosnell M; Gu ZQ; Maule A; Sigvardson K; Zhang YF Pharm Res; 2006 Feb; 23(2):440-6. PubMed ID: 16477396 [No Abstract] [Full Text] [Related]
37. Applications of solid-state NMR to pharmaceutical polymorphism and related matters. Harris RK J Pharm Pharmacol; 2007 Feb; 59(2):225-39. PubMed ID: 17270076 [TBL] [Abstract][Full Text] [Related]
38. Drug discovery. Kennedy D Science; 2004 Mar; 303(5665):1729. PubMed ID: 15031461 [No Abstract] [Full Text] [Related]
39. [Pharmacopeia and preparations for cutaneous application]. Esnault F; Etchegaray JP; Mallard C Ann Dermatol Venereol; 2007 Mar; 134(3 Pt 2):2S40-5. PubMed ID: 17563714 [No Abstract] [Full Text] [Related]
40. In vitro - in vivo correlation: from theory to applications. Emami J J Pharm Pharm Sci; 2006; 9(2):169-89. PubMed ID: 16959187 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]